Targeted therapies: a new generation of cancer treatments.
about
Pancreatic Cancer from Molecular Pathways to Treatment OpinionPancreatic cancer from bench to bedside: molecular pathways and treatment optionsRecent developments in receptor tyrosine kinases targeted anticancer therapyViro-immune therapy: A new strategy for treatment of pancreatic cancerIn vitro and in vivo models for analysis of resistance to anticancer molecular therapiesTheranostic applications of antibodies in oncology.Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsProperties of protein drug target classesDose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer PatientsBioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkersCOTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo.Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiencyAnticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Pancratistatin induces apoptosis in clinical leukemia samples with minimal effect on non-cancerous peripheral blood mononuclear cells.Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine.Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study.A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening.Prescriptions of traditional Chinese medicine are specific to cancer types and adjustable to temperature changes.Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins.Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification.Programming cancer through phase-functionalized silicon based biomaterials.Potential cytochrome P-450 drug-drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trialsEvaluation of drug-targetable genes by defining modes of abnormality in gene expression.Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.Cytotoxicity of the Sesquiterpene Lactones Neoambrosin and Damsin from Ambrosia maritima Against Multidrug-Resistant Cancer CellsA serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinomaMulti-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancerOcular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions.HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.Disparate Response to Methotrexate in Stem Versus Non-Stem CellsMedical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy.Infectious complications associated with monoclonal antibodies and related small moleculesNetwork systems biology for targeted cancer therapies.Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinateNanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes.Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus
P2860
Q26743482-52CEEEE4-0C3C-4447-93B3-25655AFF91CEQ26747524-8F5301F4-1450-4127-8D90-ECE46E86002EQ26751331-B4C946BE-C293-4758-9D09-3D9D64A55AE2Q26774641-3DE85E28-4EA6-46DC-8784-7AF014937056Q27014174-6782E00B-D805-40B5-8348-5ABFA417162FQ27693293-B2B8FEF0-162F-42CC-9E4A-1594945016ACQ28077999-B997C70C-0494-466A-A3ED-07708FE4CC25Q28545197-2B74E67B-1A17-4713-A1CC-EB3112D4C2DBQ28550661-3F5AE07D-B4F6-49A2-A708-2CFA59EF75A2Q28834154-5EC2E4B2-2788-43BD-BDBD-47EFB1F5875CQ30367429-B746CD86-CFF0-476A-9946-1CE987C6517FQ30495113-888A2538-FC7C-408F-89AA-B86D00161308Q30679405-FED1A68D-48DF-4140-97A8-A22EE0D8F0A5Q33529963-C08F9087-1B43-444D-977E-B57D6467E539Q33692555-E924133C-144C-4475-B68F-316CF0ECF7DDQ33753516-7CECDE5D-459F-4C27-A94D-78BFFC090993Q33787214-16F1A582-179E-4148-A846-AA4C1A7D4CBAQ33900003-50440827-66DA-40D9-B362-146E8821F0B5Q33972047-F081121D-632F-4755-9F11-D78EF71084CBQ34084900-F2DF0AC8-E02C-49FC-96D1-19D82207A77CQ34168327-B5656312-C50E-4212-8167-C1A2B6A2F82BQ34538361-BD12F4BD-9FE9-4887-ACC8-E68578E1F73CQ34546374-1ADF4784-F4C3-4F81-821E-7E3EB5E9E3CAQ35169263-9FE87DF1-FA3B-4B97-AA58-2E75C1F9C9EEQ35653023-024575BF-3F9D-4CA4-82F3-ED034E0D47F1Q35878347-EC36C3E3-0FB9-4124-B22E-A49FCE53F9F9Q36026699-2ABD34C6-8C3F-43C6-85E8-3AF5D1F5414BQ36244267-744E4A7F-C730-4C6A-A971-05A54BB18958Q36260937-478FC5D2-AF37-4897-8C87-256EC2108F19Q36287414-A0424C94-5567-4416-AAFB-F3038FA31067Q36325610-9F15C9B9-94F7-4C2D-B799-C28FD0C57362Q36383018-D7712D38-DDCF-4F7B-93F2-92004C816495Q36729450-7B8CBDBC-0D07-42BD-ACB4-F3AAC5C53DE0Q36936301-EBC68AA8-8E7B-42D5-9D5A-C3D0A303F8A0Q36962501-DB185F6F-5D03-4EEB-8F76-C91F730A7001Q37156636-30FC3194-75EB-468F-85A0-4BE0D983317BQ37183677-F87BA248-DEF8-4011-BE19-656423E1F615Q37313245-E2BCF114-9634-4335-9269-C43047ECB16CQ37370429-1F46362F-0EEF-43E4-805E-4AB21E3015E3Q37450403-8F2B823C-1C01-4978-B1FB-13AABD7F4492
P2860
Targeted therapies: a new generation of cancer treatments.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Targeted therapies: a new generation of cancer treatments.
@ast
Targeted therapies: a new generation of cancer treatments.
@en
Targeted therapies: a new generation of cancer treatments.
@nl
type
label
Targeted therapies: a new generation of cancer treatments.
@ast
Targeted therapies: a new generation of cancer treatments.
@en
Targeted therapies: a new generation of cancer treatments.
@nl
prefLabel
Targeted therapies: a new generation of cancer treatments.
@ast
Targeted therapies: a new generation of cancer treatments.
@en
Targeted therapies: a new generation of cancer treatments.
@nl
P1476
Targeted therapies: a new generation of cancer treatments
@en
P2093
David E Gerber
P304
P577
2008-02-01T00:00:00Z